Literature DB >> 7666970

Baseline and follow-up MRI of the internal auditory canal after suboccipital resection of acoustic schwannoma: appearances and clinical correlations.

M Smith1, M Castillo, J Campbell, H Pillsbury, T Walters.   

Abstract

Prospective baseline MRI was obtained on 31 patients who had "total" removal of acoustic schwannoma 6 months to 9 years previously. Follow-up MRI was performed after 1-2 years on patients with questionable abnormalities. We found four patterns (1) internal auditory canals (IAC) with nonenhancing soft-tissue strands, possibly scars or distorted residual nerves (8); (2) IAC with marginal enhancement-reactive dura mater (16); (3) IAC with contrast-enhancing globular tissues suggesting residual or recurrent tumour (5); (4) high-signal intensity in the IAC before contrast medium administration, probably related to graft with fat/fascia/muscle (2). Prospective 1-to 2-year follow-up studies were available in 8, 5, and 1 patients in groups 2, 3, and 4 respectively. In group 2, dural enhancement remained unchanged in 5 patients and decreased in 3. In group 3 follow-up showed 1 tumour recurrence (surgically confirmed) and 4 stable abnormalities. In group 4, follow-up in 1 of the 2 patients was stable. In groups 1 and 2, the MRI features correlate well with complete tumor removal. Whether follow-up in these groups is indicated needs to be determined. In group 3 residual or recurrent tumor cannot be excluded. In group 4, grafts may prevent adequate visualization of the IAC.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7666970     DOI: 10.1007/bf00588345

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  10 in total

1.  Gadolinium-enhanced magnetic resonance imaging in facial nerve lesions.

Authors:  S J Millen; D Daniels; G Meyer
Journal:  Otolaryngol Head Neck Surg       Date:  1990-01       Impact factor: 3.497

2.  Meninges: benign postoperative enhancement on MR images.

Authors:  J W Burke; A E Podrasky; W G Bradley
Journal:  Radiology       Date:  1990-01       Impact factor: 11.105

3.  Gadolinium-enhanced MR of the postoperative internal auditory canal following acoustic neuroma resection via the middle fossa approach.

Authors:  D P Mueller; B J Gantz; K D Dolan
Journal:  AJNR Am J Neuroradiol       Date:  1992 Jan-Feb       Impact factor: 3.825

4.  A one-stage combined approach for the management of large cerebellopontine angle tumors.

Authors:  M E Glasscock; J W Hays; C G Jackson; R L Steenerson
Journal:  Laryngoscope       Date:  1978-10       Impact factor: 3.325

5.  Facial nerve function in cerebellopontine angle tumor surgery.

Authors:  G Gardner; J H Robertson
Journal:  Am J Otol       Date:  1985-11

6.  Cranial postoperative site: MR imaging appearance.

Authors:  C F Lanzieri; M Larkins; A Mancall; R Lorig; P M Duchesneau; S A Rosenbloom; M A Weinstein
Journal:  AJNR Am J Neuroradiol       Date:  1988 Jan-Feb       Impact factor: 3.825

7.  Hearing preservation--posterior fossa approach.

Authors:  N L Cohen; J Ransohoff
Journal:  Otolaryngol Head Neck Surg       Date:  1984-04       Impact factor: 3.497

8.  A systematic approach to the surgical management of acoustic neuroma.

Authors:  M E Glasscock; J F Kveton; C G Jackson; S C Levine; K X McKennan
Journal:  Laryngoscope       Date:  1986-10       Impact factor: 3.325

9.  Cranial postoperative site: assessment with contrast-enhanced MR imaging.

Authors:  A D Elster; D A DiPersio
Journal:  Radiology       Date:  1990-01       Impact factor: 11.105

10.  Growth rate of acoustic neuromas.

Authors:  G E Valvassori; M Guzman
Journal:  Am J Otol       Date:  1989-05
  10 in total
  3 in total

1.  Residual and recurrent acoustic neuroma in hearing preservation procedures: neuroradiologic and surgical findings.

Authors:  A Mazzoni; V Calabrese; L Moschini
Journal:  Skull Base Surg       Date:  1996

Review 2.  Evaluating growth trends of residual sporadic vestibular schwannomas: a systematic review and meta-analysis.

Authors:  Abdullah Egiz; Hritik Nautiyal; Andrew F Alalade; Nihal Gurusinghe; Gareth Roberts
Journal:  J Neurooncol       Date:  2022-06-27       Impact factor: 4.506

Review 3.  Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.

Authors:  Scott R Plotkin; Chris Halpin; Jaishri O Blakeley; William H Slattery; D Bradley Welling; Susan M Chang; Jay S Loeffler; Gordon J Harris; A Gregory Sorensen; Michael J McKenna; Fred G Barker
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.